<html><body><pre>
[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6009 Introduced in House (IH)]

&lt;DOC&gt;






117th CONGRESS
  1st Session
                                H. R. 6009

 To provide that the public health emergency declared with respect to 
 COVID-19 shall terminate on the date on which the Secretary of Health 
  and Human Services approves, or authorizes emergency use of, a drug 
                      intended to treat COVID-19.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           November 17, 2021

 Mr. Schweikert (for himself, Mr. Fallon, and Mr. Gohmert) introduced 
 the following bill; which was referred to the Committee on Energy and 
                                Commerce

_______________________________________________________________________

                                 A BILL


 
 To provide that the public health emergency declared with respect to 
 COVID-19 shall terminate on the date on which the Secretary of Health 
  and Human Services approves, or authorizes emergency use of, a drug 
                      intended to treat COVID-19.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Pandemic Cessation Act''.

SEC. 2. TERMINATION OF COVID-19 PUBLIC HEALTH EMERGENCY.

    (a) In General.--The public health emergency declared pursuant to 
section 319 of the Public Health Service Act (42 U.S.C. 247d) on 
January 31, 2020, with respect to COVID-19, and any renewal thereof, 
shall terminate on the first date after the date of enactment of this 
Act on which the Secretary of Health and Human Services--
            (1) grants approval under section 505 of the Federal Food, 
        Drug, and Cosmetic Act (21 U.S.C. 355) to an application with 
        respect to a new drug intended to treat COVID-19; or
            (2) authorizes emergency use under section 564 of such Act 
        (21 U.S.C. 360bbb-3) with respect to a drug intended to treat 
        COVID-19.
    (b) Definition.--In this section, the terms ``drug'' and ``new 
drug'' have the meanings given such terms in section 201 of the Federal 
Food, Drug, and Cosmetic Act (21 U.S.C. 321).
                                 &lt;all&gt;
</pre></body></html>
